Navigation Links
Women Health Care Executives Names Genomic Health President Kimberly Popovits as 'Woman of the Year'
Date:3/3/2008

Popovits to be Honored at Gala Dinner in San Francisco on June 12, 2008

SAN FRANCISCO and REDWOOD CITY, Calif., Mar. 3 /PRNewswire/ -- Women Health Care Executives of Northern California (WHCE) announced today that Kimberly Popovits, president and chief operating officer of Redwood City-based Genomic Health, Inc., has been named its 2008 "Woman of the Year." Popovits will be honored at a gala dinner to be held at the Carnelian Room atop the Bank of America building in San Francisco on June 12, 2008.

"The WHCE board of directors always has many impressive candidates to choose from, and this year was no exception," said WHCE President Kimberly Werninghaus Blair. "But Kim Popovits' professional accomplishments, the many people and lives she has impacted, and the contributions her work has made to the larger medical and biopharmaceutical communities gave us a clear choice for our 2008 Woman of the Year."

Popovits has been a leader in the biopharmaceutical industry for more than 25 years. She spent 15 years as head of commercial operations at Genentech, where she led the successful commercialization of 14 new therapies, including Herceptin(R), the cancer treatment drug that revolutionized the way doctors treat a particularly aggressive form of breast cancer. Herceptin is often touted as the first "targeted therapy," that is, one based on an individual's unique genetic profile, and that it has helped to usher in the age of "personalized medicine." As Genomic Health's president and chief operating officer, Popovits helped bring yet another first-of-its-kind product to women: the Oncotype(R) DX breast cancer test, which predicts whether a woman's cancer will return and how likely she is to benefit from chemotherapy based on the genomic makeup of her tumor. Thanks to her pioneering mentality and perseverance with physicians and payers, more than 46,000 women to date have benefited from the individualized information that Oncotype DX provides in making their personal breast cancer treatment decisions.

"We're pleased and proud that a society dedicated to advancing women's careers in health care has recognized Kim as its 2008 Woman of the Year," said Randy Scott, Ph.D., chairman and CEO of Genomic Health. "Kim is a passionate and accomplished leader who consistently puts the needs of patients first, while inspiring women in our company and throughout the health care industry. She truly is a role model for us all."

Women Health Care Executives of Northern California (WHCE) is a dynamic community of women health care professionals in the Bay Area, who encourage and inspire each other throughout the development of their careers. For more information about WHCE and Woman of the Year, including sponsorship opportunities, please visit http://www.whce.net or contact Kimberly A. Read at 510-991-6748.

Genomic Health, Inc. (Nasdaq: GHDX), is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype D(R), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.


'/>"/>
SOURCE Women Health Care Executives of Northern California
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Work-Family Conflict Dogs Air Force Women After Deployment
3. Work-Family Conflict Dogs Air Force Women After Deployment
4. Antioxidant Supplements May Raise Womens Skin Cancer Risk
5. Early Weight Loss in Women Linked to Dementia
6. For Health Info, Women Often Turn to the Web
7. Smoking increases risks for head and neck cancers for men and women
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Passive smoking increases sleep disturbance among pregnant women
10. Trial to Test Gene Therapy for Angina in Women
11. Exercise and yoga improves quality of life in women with early-stage breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... News Advisory/Interview Opportunity , After six years of advocacy, ... in Europe for public health and the environment and is calling on the United ... and the overwhelming support of European citizens, the European Union (EU) will, beginning next ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest multi-specialty ... payment system, to expand its focus on patient care by providing an advanced ... , “At Ogden Clinic, we are working to become a different type of ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex ... of “Profiling protein expression in circulating tumor cells using microfluidic western blotting” in ... of the Vortex technology to capture CTCs and a microfluidic single-CTC ...
(Date:3/22/2017)... ... 22, 2017 , ... Sam & Associates Insurance Agency, a ... related services to residents of the region, is embarking on a charity effort ... wild lands. , Endangered Species International is committed to ending the anthropogenic trends ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... consuming and frustrating and this tool bypasses that. Healthcare facilities across the ... an opportunity to offer their clients and hospitals, across the country, an efficient ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... NEW YORK , March 22, 2017 ... ... cannabis market was worth an estimated $6.6 billion in 2016, and ... of 16% or reaching more than $24 billion by 2025. The ... 2025, or growing from $4.7 billion in 2016, to an estimated ...
(Date:3/22/2017)... 22, 2017 FinancialBuzz.com News Commentary ... rapidly due to the significant development and innovation in ... Market Research, the global electrophysiology market was worth $3.42 ... billion by 2022, with a GAGR of 13.4%. Electrophysiology ... diagnose abnormal heartbeats or arrhythmia. The report indicates that ...
(Date:3/22/2017)... MAPLE GROVE, Minn. , March 22, 2017   ... of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and ... (clomipramine hydrochloride) Capsules USP. The clomipramine ... for the 12 months ending December 2016, according to IMS ... ...
Breaking Medicine Technology: